WELCOME TO CERN-MEDICIS !
NEWS!
- 09/2026
medical-radionuclides.eu (prismap +) is online! an impressive number of applications have been received !
- 04/2026
The Programme for 2026 has restarted with mass separation of external targets or long-lived CERN sources, with an exciting scientific programme ahead combining proof-of-concept and clinical translation of MEDICIS High Molar Activity grade radionuclides.
- 01/2026
Happy new year from the MEDICIS team and support groups !
- 01/2026
PRISMAP has delivered its last radionuclide last December, the programme coordinated by CERN with MEDICIS mass separation had been a large success, as reported now on CERN website .
- 07/2025
A delegation including IAEA DDG Najat Mokhtar visiting the facility while a first test for Ac-226 theranostic alpha emitter metrology was performed onsite by NPL-Dr Sean Collins.
- 04/2025
The facility has restarted after its shutdown, with an exciting programme ahead – We may witness the 1st use of MEDICIS-separated treatment radionuclides in clinical research in hospitals after the positive decision of the CERN Council.
- 12/2024
CERN hosted (in room Curie !) the 13th MEDICIS collaboration board followed by the 7th Anniversary of the first collected radionuclide!
- 09/2024
CERN hosted the 21st Plenary Meeting of the European Observatory on the the Supply of Medical Radionuclides on 25 and 26 of September 2024.
JOB OPPORTUNITIES
IFE/NCCR (NO) is recruiting 2 permanent nuclear scientists (chemist and applied scientist)
GRANTS & DONATIONS – CERN & Society Foundation
The CERN KT-Fund
La Fondation pour l’innovation sur le cancer et la biologie
The ADAM company
The FWO
PRISMAP, EURAMED (H2020), PRISMAP+ Horizon Europe
